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ABSTRACT
BOLD RESPONSES TO INHIBITION IN CANNABIS USING ADOLESCENTS AND
EMERGING ADULTS
by
Alexander L. Wallace
The University of Wisconsin-Milwaukee, 2019
Under the Supervision of Professor Krista M. Lisdahl
Cannabis use has been associated with increased blood oxygen level dependent (BOLD)
responses absent of behavioral deficits during a response inhibition task compared to controls.
We investigated whether gender and cannabis use result in differences in BOLD responses and
behavioral performance during a Go-NoGo task. Participants included eighty-three 16-26 year
olds (MJ=36, Controls=46). An emotion based Go-NoGo task required participants to inhibit
their response during a “neutral” face. A whole-brain analysis looked at differences between
cannabis group, gender, and their interaction. Significant increased BOLD responses were
observed in cannabis users compared to controls in the left frontal cortex, left cingulate cortex,
and the left thalamus during correct response inhibitions. There were no significant differences
on task performance or group by gender interactions. Supporting previous research, cannabis
users showed increased BOLD responses in core areas associated with response inhibition during
a Go-NoGo task further elucidating the relationships between cannabis and brain-behavior.
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Cannabis use remains one of the most commonly used drugs by adolescents and
emerging adults with 37.1% of high school seniors and approximately 35.3% of young adults
(aged 19-28) reported using cannabis in the past 12 months (Johnston et al., 2018; Schulenberg
et al., 2017). Due to the ongoing brain development during this time (Giedd et al., 1999),
research suggests that adolescent cannabis use has significant negative impact on brain structure
and function (Crane, Schuster, Fusar-Poli, & Gonzalez, 2013; Lubman, Cheetham, & Yücel,
2015; A. D. Schweinsburg, Brown, & Tapert, 2008).
Cannabis contains the compound Δ9-tetrahydrocannabional (THC), which is responsible
for its psychoactive effects (Hall & Solowij, 1998). THC bonds with cannabinoid receptors that
are located within both the central and peripheral nervous system (Mackie, 2005). The
cannabinoid receptor 1 (CB1) is the most abundant cannabinoid receptor found in the brain
(Chevaleyre, Takahashi, & Castillo, 2006) and stimulation of CB1 is responsible for the
psychoactive effects of THC (Mackie, 2005; Wilson & Nicoll, 2002). High density of CB1
receptors have been found in the amygdala (Katona et al., 2001), basal ganglia (Herkenham et
al., 1991), hippocampus (Herkenham et al., 1991; Jansen, Haycock, Ward, & Seybold, 1992),
and prefrontal and parietal cortices (Auclair, Otani, Soubrie, & Crepel, 2000). In these regions,
THC binds with CB1 receptors primarily on presynaptic gamma-aminobutyric acid (GABA)
neurons to inhibit and excite neurotransmitter activity such as glutamate, dopamine,
acetylcholine, and serotonin (Katona et al., 1999; Lopez-Moreno, Gonzalez-Cuevas, Moreno, &
Navarro, 2008). Disruption of the natural endocannabinoid system during development by
repeated exogenous cannabis may result in neurocognitive deficits, especially in CB1-rich areas
underlying executive functioning (Casey, Getz, & Galvan, 2008; Casey & Jones, 2010; Lisdahl,
Gilbart, Wright, & Shollenbarger, 2013; Lopez-Moreno et al., 2008).
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Executive functioning is a core cognitive function responsible for engaging in purposeful,
independent, self-directed behaviors (Lezak, 2012). Facets of executive functioning include
planning and decision-making, selective attention, volition, task-switching, and behavioral
inhibition (Hofmann, Schmeichel, & Baddeley, 2012; Lezak, 2012). Prior work has reported that
chronic cannabis use has been linked with executive functioning deficits (Gonzalez et al., 2012;
Grant, Chamberlain, Schreiber, & Odlaug, 2012; Hanson et al., 2010; Harvey, Sellman, Porter, &
Frampton, 2007; Lisdahl & Price, 2012; Mathias et al., 2011; Medina et al., 2007; Schuster,
Crane, Mermelstein, & Gonzalez, 2012). Specifically, studies have shown that cannabis use is
associated with decreased complex attention (Hanson et al., 2010; Lisdahl & Price, 2012;
Mathias et al., 2011; Medina et al., 2007; Tapert, Baratta, Abrantes, & Brown, 2002), verbal
working memory deficits, (Becker, Collins, & Luciana, 2014; Dougherty et al., 2013; Hanson et
al., 2010; Medina et al., 2007; Solowij et al., 2011), poorer decision making (Becker et al., 2014;
Churchwell, Lopez-Larson, & Yurgelun-Todd, 2010; Gonzalez et al., 2012; Grant et al., 2012),
and planning (Grant et al., 2012; Medina et al., 2007). With continued links between substance
use and response inhibition (Fillmore & Rush, 2002; Monterosso, Aron, Cordova, Xu, &
London, 2005; Nigg et al., 2006) and increased calls to examine inhibitory control as a future
predictor of use (Ivanov, Schulz, London, & Newcorn, 2008) the role of cannabis on areas of the
brain related to inhibition has garnered particular interest.
Inhibition is a key component to executive control and attention that is best defined as the
ability to suppress responses to a stimulus (Aron, 2007). The concept of inhibition is complex
and can be broken down into 4 subsets or processes, interference control, cognitive inhibition,
behavioral inhibition, and oculomotor control (Nigg, 2000). While these differing inhibitory
processes have distinct implications, the subtype that has garnered significant interest is the role
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of behavioral inhibition, also thought of as response inhibition (Aron, 2007; Chambers, Garavan,
& Bellgrove, 2009; Ridderinkhof, van den Wildenberg, Segalowitz, & Carter, 2004). Behavioral
inhibition is one’s ability to suppress automatic/prepared/cued responses to a task, which is often
measured through tasks such Go-NoGo or Stop tasks (Nigg, 2000). With continuing advances in
imaging data, the relationship between response inhibition performance on these tasks and the
brain has garnered increasingly more research interest.
While it has long been known that the process of inhibition has been linked to the
prefrontal cortex (Holmes, 1938), extensive research has been done to uncover the specific
regions associated with response inhibition. In particular, regions of the prefrontal cortex
including the inferior frontal gyrus (IFG) [both right (Aron, Fletcher, Bullmore, Sahakian, &
Robbins, 2003; Aron, Robbins, & Poldrack, 2004, 2014; Hampshire, Chamberlain, Monti,
Duncan, & Owen, 2010) and left (Swick, Ashley, & Turken, 2008)], dorsomedial prefrontal
cortex (Garavan, Ross, Murphy, Roche, & Stein, 2002), and the anterior cingulate cortex (Carter
& van Veen, 2007). Regions outside of the prefrontal cortex have also been implicated in
response inhibition, in particular the basal ganglia (Chambers et al., 2009; Rieger, Gauggel, &
Burmeister, 2003), which is associated with motor suppression. Due to the varying regions that
play a role in inhibition, problems within this cognitive domain may be linked to damage or
dysfunction within several of the aforementioned regions. Further, as adolescents emerge into
young adulthood, these regions in particular experience neuromatruation (Casey et al., 2008; T.
L. Jernigan, Trauner, Hesselink, & Tallal, 1991). The regular exposure of exogenous cannabis
during this developmental period may significantly disrupt the functioning of these neuronal
networks (Casey & Jones, 2010; Ehrenreich et al., 1999; A. D. Schweinsburg et al., 2008).
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As mentioned above, cannabis use has been associated with inhibitory deficits on tasks
such as the Stroop (Battisti et al., 2010; Fontes et al., 2011; Gruber & Yurgelun-Todd, 2005),
Go-NoGo related tasks (Bolla, Brown, Eldreth, Tate, & Cadet, 2002), and decision making tasks
(Solowij et al., 2012). These inhibitory deficits have been shown to moderate the relationship
between cannabis use and negative behavioral outcomes, such as risky sexual behavior (Schuster
et al., 2012). While these deficits have been shown within attention based tasks (Battisti et al.,
2010; Bolla et al., 2002; Fontes et al., 2011; Gruber & Yurgelun-Todd, 2005; Solowij et al.,
2012) and self-report measures (Gruber, Silveri, Dahlgren, & Yurgelun-Todd, 2011), some
studies suggest that no observable differences with response inhibition in young adult cannabis
users (Gonzalez et al., 2012; Grant et al., 2012). It is possible that there are still subtle
differences in the inhibitory network, even in the absence of downstream behavioral deficits.
Further, cannabis users have shown increased activity in attention based networks (Abdullaev,
Posner, Nunnally, & Dishion, 2010) and cerebral blood flow in brain regions pertinent to
inhibition (Vaidya et al., 2012) during tasks requiring executive function. These findings suggest
that cannabis users require increased effort or compensatory resources in order to inhibit
responses.
Only a handful of imagining studies have directly examined BOLD responses cannabis
users engaging in an inhibitory functional magnetic resonance imaging (fMRI) task (Behan et al.,
2014; Gruber & Yurgelun-Todd, 2005; A. M. Smith et al., 2011; Tapert et al., 2007). These
studies have largely found that while there are no significant behavioral differences in task
performance, adolescent and young adult cannabis users display significantly more BOLD
activation in brain regions related to response inhibition compared to controls (J. L. Smith,
Mattick, Jamadar, & Iredale, 2014; Tapert et al., 2007). Across multiple studies, cannabis users
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were shown to have greater BOLD responses within brain regions of interest (ROI’s) that are
linked with inhibitory processes as well as recruited additional neighboring brain regions to
complete the inhibitory task. Specifically, cannabis users demonstrated aberrant activation in the
anterior cingulate cortex (Gruber, Dahlgren, Sagar, Gonenc, & Killgore, 2012; Hester, Nestor, &
Garavan, 2009), right insula (Hester et al., 2009; A. M. Smith et al., 2011; Tapert et al., 2007),
dorsolateral prefrontal cortex (Gruber & Yurgelun-Todd, 2005; A. M. Smith et al., 2011; Tapert
et al., 2007), superior frontal gyri (Behan et al., 2014; J. L. Smith et al., 2014; Tapert et al.,
2007), inferior frontal gyri (Behan et al., 2014; J. L. Smith et al., 2014), and inferior parietal
lobules (Behan et al., 2014; A. M. Smith et al., 2011; Tapert et al., 2007) during inhibitory tasks.
However, these studies notably had relatively small samples (N=18-35) and were predominately
male; thus, additional research is needed to understand neuronal response to inhibitory control
tasks in cannabis users.
Of further interest is whether gender moderates these effects. As mentioned above, most
neuroimaging studies looking at cannabis use with response inhibition are predominately male.
In animal models, THC exposure has been shown to down-regulate CB1 receptors more in
female brains compared to their male counterparts (Burston, Wiley, Craig, Selley, & Sim‐Selley,
2010). Through ovarian hormones, female rats have also been shown to have significantly
decreased density of CB1 receptors in the prefrontal cortex and amygdala compared to males as
well as a more hyperactive profile and lower prepulse inhibition (Paola Castelli et al., 2014).
These findings suggest that female populations may be more susceptible to neurocognitive
deficits from cannabis that were highlighted above. However, while these findings within
animal models are important, gender effects of cannabis and cognition in human populations
have been limited (Craft, Marusich, & Wiley, 2013; Fattore & Fratta, 2010).
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Most human studies to date have not reported gender differences in the effects of
cannabis on verbal learning (Crane, Schuster, & Gonzalez, 2013; Solowij et al., 2011), memory
(Pope, Jacobs, Mialet, Yurgelun-Todd, & Gruber, 1997; Solowij et al., 2011), and inhibitory
control (Crane, Schuster, & Gonzalez, 2013). However, two studies have found that male
cannabis users demonstrated impaired psychomotor speed (Lisdahl & Price, 2012) and poorer
decision making (Crane, Schuster, Fusar-Poli, et al., 2013) compared to male controls while
females did not show this effect. In contrast, studies have found that heavier using females
cannabis users demonstrated poorer visuospatial (Pope et al., 1997) and verbal memory
compared to male cannabis users (Crane, Schuster, & Gonzalez, 2013). Further, female
adolescent cannabis users have shown marginally increased prefrontal cortex volumes and larger
right amygdala volumes compared to female controls (McQueeny et al., 2011; Medina et al.,
2009). While these findings have not been replicated within functional studies, these altered
brain volumes suggest that female cannabis users may be at greater risk from cannabis exposure
compared to male users. However, these gender findings are still in the preliminary stages and
animal models examining gender and cannabis remain relatively mixed (Crane, Schuster, FusarPoli, et al., 2013),. Most notably, gender differences in the impact of cannabis use on inhibition
are particular scarce. While studies have largely not found any gender differences in response
inhibition between cannabis users and their non-using counterparts, these studies also did not
observe deficits with inhibition in cannabis users at all and did not examine fMRI BOLD
response (Crane, Schuster, & Gonzalez, 2013; Lisdahl & Price, 2012).
The purpose of the current study is to investigate the relationship between cannabis use
and brain functioning during an inhibitory task and how these effects may differ between males
and females. We hypothesize that despite having similar behavioral performance on an fMRI
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task, cannabis users will demonstrate significantly increased BOLD responses compared to
controls during correct inhibitions on the Go-NoGo task in the right dorsolateral prefrontal
cortex, bilateral medial frontal, bilateral inferior and superior parietal lobules, middle, inferior,
superior frontal gyri, and in neighboring brain regions as well as aberrant BOLD responses in the
anterior cingulate cortex. Finally, we hypothesize that there will be altered functional activity
between male and female users, with female users experiencing increased compensatory BOLD
activation and increased help from neighboring brain regions of key inhibitory ROIs during
successful inhibitions on the Go-NoGo task compared to male users and controls.
Method
Participants
The proposed study utilized data from 82 participants collected from a larger parent study
investigating frontolimbic functioning in cannabis using youth (R01 DA030354; PI: Lisdahl).
Participants were recruited through flyers and advertisements in the local community and college
campuses. Participants were included if they were 16-26 years-old, right handed, spoke English,
were willing to abstain from substance use over a 3-week period, and fit into either a cannabis
user or non-user (see below). Exclusion criteria included having an independent DSM-IV Axis I
(attention, mood, anxiety or psychotic) disorder in the past year, major medical or neurological
disorders, traumatic brain injury or head trauma (loss of consciousness >2 minutes), history of
learning disability or intellectual disability, prenatal medical issues or premature birth (gestation
<35 weeks), reported prenatal alcohol/illicit drug exposure, inability to complete exercise
physiology testing, or excessive other drug use (>20 times of lifetime use for each drug
category). Cannabis Users (n=36): In order to capture current cannabis users, cannabis users had
to have endorsed using cannabis greater than 40 times in the past year (nearly weekly). Controls
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(n=46) were defined as having abstained from using cannabis more than 5 times in the past year.
A total of 44 males and 38 females were included in the study. After grouping participants into
cannabis users and controls, cannabis users included 21 males and 25 females (Males=46%) and
controls include 23 males and 13 females (Males=64%).
Procedures
All procedures were IRB-approved through the University of Wisconsin – Milwaukee
and the Medical College of Wisconsin. Potential participants who expressed interest in the parent
study were screened through an initial semi-structured interview for independent past-year Axis I
disorders other than substance use disorder (SUD) over the phone. If determined eligible, study
staff obtained written consent from participants (aged 18 or older). All minors below 18 years of
age provided written assent after parent consent was acquired. Participants who were deemed
ineligible were informed and compensated, but not told the specific reasons for failed inclusion.
Participants who were eligible for the study came in for five study sessions over the
course of three weeks. Data from the baseline session (day 1) and fourth session (day 20 of 21)
are assessed here. Participants completed a series of psychological questionnaires, drug use
interview, neuropsychological battery, and an MRI scan over the course of three weeks. During
that period, participants were required to remain abstinent from alcohol, cannabis, and other drug
use, which was confirmed through urine and sweat toxicology screening.
Measures
MINI Psychiatric Interview. To rule out for potential Axis-I Disorders to prevent
comorbid psychiatric history from confounding results, participants and parents of participants
over 18 were given the Mini International Psychiatric Interview (MINI) (Sheehan et al., 1998),
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and participants and parents of participants under 18 were given the MINI-Kid (Sheehan et al.,
2010).
Customary Drinking and Drug Use Record. To determine lifetime patterns of drug and
alcohol use, youth participants were given the Customary Drinking and Drug Use Record
(CDDR) (Brown et al., 1998) at baseline. The CDDR measured the frequency of alcohol,
nicotine, cannabis, and other drug use, substance use disorder symptoms, and the age of onset for
first time substance use as well as regular weekly use.
Timeline Followback. Timeline Follow-Back interviews were conducted with all
participants to measure substance use patterns over the past year (Sobell & Sobell, 1992).
Utilizing memory cues of common holidays and personal events, participants were asked to
describe the frequency of their drug use over the past year by a month-to-month basis. Memory
cues were adapted to be appropriate to both adolescents and emerging adults and included things
such as developmental milestones, school grades, and relationship changes. Substances were
measured by standard units [alcohol (standard drinks), nicotine (number of cigarettes and hits of
chew/snuff/pipe/cigar/hookah), cannabis (all methods converted to joints or mg in concentrates),
ecstasy (number of tablets), sedatives (number of pills or hits of downers and GHB), stimulants
(cocaine and methamphetamine use converted to mg and number of amphetamine pills),
hallucinogens (number of hits or uses of ketamine/salvia/shrooms/other hallucinogens), opioids
(number of hits of heroin/opium), and inhalants (number of hits)].
Drug Toxicology/Abstinence Testing. To insure abstinence during the course of the study,
participants were required to complete immediate urine drug toxicology screenings. Screenings
were conducted using ACCUTEST SplitCup to test for the presence of the following substances:
amphetamines (1000 ng/ml), barbiturates (300 ng/ml), benzodiazepines (300 ng/ml), cocaine
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(300 ng/ml), ecstasy (MDMA; 500 ng/ml), methadone (300 ng/ml), methamphetamine (1000
ng/ml), opiates (2000 ng/ml), PCP (25 ng/ml), and THC (marijuana; 50 ng/ml). Further, NicAlert
was also used to measure cotinine levels within participants’ urine samples. Participants were
also required to wear PharmChek Drugs of Abuse Patches throughout the duration of the study.
Sweat drug patches were made of a semi-permeable polyurethane membrane that allowed for the
natural secretion of water/sweat, but collects heavier molecules such as illicit drugs. In this way,
drug use that quickly leaves the system, such as amphetamines, would be detected during the
week period between testing sessions. Sweat patches were tested for amphetamine,
methamphetamine, opiates, cocaine metabolites, PCP, and THC.
CPT. The Conners Continuous Performance Task (CPT) is a 14 minute long task that
required individuals to respond to stimuli on a computer screen (Conners et al., 2000).
Participants were asked to respond to all letters except for the letter “X” which they should try to
stop themselves from pressing the response button. During this task, average reaction time across
all “go” trials were recorded. Previous research has shown that cannabis users have significantly
differed from controls on reaction time during this task (Wallace, Wade, Hatcher, & Lisdahl,
2018).
fMRI Affective No-Go Task. Participants were exposed to a Go-NoGo task featuring faces
expressing feelings of happy, fearful, or calm that had been originally designed by the research
group at Sackler Institute for Developmental Psychobiology (Hare et al., 2008; Somerville, Hare,
& Casey, 2011). For this NoGo task, two facial expressions were used within a trial. Using a
rapid event-related design, participants were told what particular stimuli/expression they should
respond to by hitting a target box (Go), and what stimuli/expression they should stop themselves
from responding and hitting the target box (NoGo). For each trail, faces would appear for 500

10

milliseconds followed by a jittered intertrial interval ranging from 2 to 14.5 seconds in duration.
In each run, the participants were exposed to 48 trials that were presented is a pseudorandomized
order (35 “go” trials and 13 “nogo” trials). Participants completed six trials, which allowed
every combination of happy, fearful, and calm expressions to appear as a Go and NoGo trial for
each participant. Further, for each trial, participants were instructed to respond as fast as
possible and not wait for the target/nontarget stimuli, but also try to make as few errors as
possible.
MRI Data Acquisition
MRI scans were acquired on a 3T Signa LX MRI scanner (GE Healthcare, Waukesha,
WI) using a 32-channel quadrature transmit/receive head coil. High-resolution anatomical
images were acquired using a T1-weighted spoiled gradient-recalled at steady-state (SPGR)
pulse sequence (TR = 8.2 ms, TE = 3.4 s, TI = 450 and flip angle of 12°). The in-plane resolution
of the anatomical images was 256x256 with a square field of view (FOV) of 240 mm. One
hundred fifty slices were acquired at 1 mm thickness.
MRI Pre-Processing Plan
Data were processed and analyzed using Analysis of Functional NeuroImages (AFNI
(Cox, 1996)) and Matlab (Matheworks, 2012). Imaging data were processed through a standard
preprocessing pipeline within AFNI. To account for high and low frequency artifactual signals
caused by hardware instabilities, head motion, and physiological changes, the time series per
each voxel were “despiked” and these isolated spikes were replaced to fit the modeled data for
the voxel utilizing 3dDespike. Further, the first 3 TRs (time it took to conduct one full scan)
were removed to eliminate initial scanner “noise.” Voxel time series were corrected so that all
acquired data is aligned to the same temporal spot of origin utilizing AFNI’s 3dTshift. To further
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reduce the influence of head motion within the BOLD signal, volume registration were registered
based on the volume run with the least amount of motion artefacts within the dataset and then
warped into standard Montreal Neurological Institute (MNI) coordinate space (Mazziotta et al.,
2001) by making use of AFNI’s 3dVolreg. Using 3dmerge, data were spatial smoothed using a
Gaussian function using the default 4mm full width at half maximum (FWHM) to blur data to
half of other surrounding voxels. Each voxel was scaled by default to a mean of 100 to allow for
interpretation of echo-planar imaging (EPI) values as a percentage of the mean. Data was
deconvolved using AFNI’s 3dDeconvolve (Ward, 2000). Data was convolved after a gamma
variate function. Further, six motion parameters were regressed out (roll, pitch, yaw, ds, dl, and
dp) to account for motion artifacts. Data points of incorrect responses on the Go-NoGo trial were
removed from data in order to compare correct neutral Go-NoGo stimuli across cannabis users
and controls. In this way, we only examined correct inhibitory responses to the neutral NoGo
stimuli. Bold signal responses during these correctly inhibited neutral NoGo were used to
compare across cannabis users and controls.
Statistical Analyses
Preliminary Analysis. Analyses were conducted utilizing AFNI with follow-up analyses
occurring in SPSS. All statistical decisions were made at a p value less than .05. Demographic
information was examined using chi-square and ANOVA testing. Successful NoGo performance
between both groups were observed to determine if cannabis users and controls have similar
rates of accuracy during the task. Group comparisons on these commission errors were evaluated
using an ANCOVA with past year alcohol use as a covariate.
Primary Analysis. BOLD responses were compared across subject’s time series at points
when subject’s correctly inhibited their response during a neutral NoGo stimuli. In order to
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optimize the number of neutral NoGo data points per a subject, trials that included both happy
Go and fearful Go were concatenated together. However, as a follow-up analysis, correct neutral
NoGo responses were compared between both the happy Go and fearful Go trials. To examine
group differences, a voxel by voxel ANCOVA was conducted using AFNI’s 3dMVM at a voxelwise p-value of p=.01. Monte carlo simulation for cluster-thresholding was completed using
3dFWHM and 3dClustSim (Forman et al., 1995) to control for multiple comparisons at a p-value
of .05. In order to investigate whether gender moderates the effect between cannabis use and
BOLD responses, AFNI’s 3dMVM incorporated models including gender and cannabis use. In
this way, F-statistical maps were computed to determine significant interactions between gender
and cannabis use after controlling for past year alcohol use as a covariates. Similar to the primary
analyses, cluster-thresholding was conducted using 3dClustSim (Forman et al., 1995).
Follow-Up Analyses. In order to examine brain-behavior relationships, significantly
different ROI clusters between cannabis users and non-users were extracted into SPSS (beta
weights) and correlated with CPT-II scores.
Results
Demographics
Controls and cannabis users did not significantly differ in age (t(80)=-.842, p=0.40),
years of education (t(80)=.98, p=0.31), race (χ2=3.83, p=0.70), ethnicity (χ2=3.62, p=0.16), or
gender (χ2=2.70, p=0.10). Demographic information is displayed in Table 1.
Table 1.
Demographics

MJ Users

Age
(M,SD)

Race
(% Caucasian)

Ethnicity
(% Not Hispanic)

Gender
(% Male)

21.6 (2.2)

58.3%

77.8%

63.9%
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Years of
Education
(M,SD)
14.0 (1.5)

Controls

21.1 (2.5)

65.2%

89.1%

45.7%

14.4 (2.1)

Notes. *MJ denotes the cannabis user group

Substance Use
Controls had on average .54 cannabis uses in the past year (SD=1.17, Min=0.00,
Max=4.75), used alcohol on average 132.97 times in the past year (SD=189.23, Min=0.00,
Max=698.50), and used an average of 25.82 cigarettes in the past year (SD=171.71, Min=0.00,
Max=1165.00). Cannabis users had 425.51 cannabis uses on average in the past year
(SD=441.75, Min=44.70, Max=2306.00), alcohol 331.52 on average in the past year
(SD=299.52, Min=0.00, Max=1120.50), and 184.59 cigarettes in the past year (SD=460.91,
Min=0.00, Max=1867.00). Cannabis users last reported cannabis use on average was 31.08 days
(SD=22.90, Min=17.00, Max=150) before the MRI scan (including the 3 weeks of monitored
abstinence). As expected, cannabis users and controls differed significantly on past year cannabis
use (t(35)=5.78, p<.001) and past year alcohol use (t(56)=3.47, p=.001). Past year nicotine use
was not significantly different between cannabis users and controls (t(43)=1.96, p=.06). Due to
the significant differences in alcohol use, past year alcohol use will be incorporated into the
statistical analyses.
Behavioral Measures
Cannabis users did not significantly differ on the number of incorrect responses to fMRI
Neutral NoGo stimuli (M=1.58, SD=1.75) compared to controls (M=2.44, SD=2.41, t(80)=-1.78,
p=.08). These findings were also non-significant after controlling for alcohol (cannabis users:
estimated mean=1.78, SE=0.37; controls: estimated mean=2.28, SE=0.32) (F(1)=.824, p=0.37).
There were no significant differences between males and females on incorrect NoGo responses
(t(80)=0.133, p=0.89). Cannabis users did not significantly differ on Go stimulus reaction time
(M=541.12, SD=90.82) compared to controls (M=518.20, SD=79.07, t(80)=1.22, p=.23) nor did
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cannabis users differ on omission errors (M=1.08, SD=1.59) compared to controls (M=2.02,
SD=3.96, t(80)=-1.34, p=.18).
fMRI Responses
Cannabis Effects. Whole brain analyses showed that during correct inhibitory responses
to neutral NoGo trials, cannabis users showed significant clusters of increased BOLD responses
in the left Cingulate Gyrus, the left Superior Frontal Gyrus, the left Thalamus, the left Medial
Frontal Gyrus, and right Cerebellum compared to their control counterparts (see Table 2, Figure
1). Cannabis users did not display any significant clusters of decreased BOLD activation
compared to controls.
Table 2.
Regions of Increased BOLD Responses in Cannabis Users

1

167

MNI coordinatesa
Peak x
Peak y
Peak z
+4.5
-19.5
+37.5

2

102

+22.5

-49.5

+22.5

Left Superior Frontal Gyrus

0.71082

3

101

+4.5

+13.5

+7.5

Left Thalamus

0.68041

4

74

+7.5

-58.5

-1.5

Left Medial Frontal Gyrus

0.70428

5

73

-31.5

+67.5

-25.5

Right Declive (Cerebellum VI)

0.70518

Cluster #

Voxels

Annotations

Effect Size
Cohen’s d

Left Cingulate Gyrus

0.69908

Notes. aMNI coordinates refer to peak signal intensity group difference within the cluster

Figure 1.
BOLD Responses in Cannabis Users vs. Controls

Figure 1. Displays regions of increased significant BOLD responses in cannabis users compared to controls during correct
inhibitions during “neutral” NoGo trials. Increased BOLD responses in the left Superior Frontal Gyrus, left Cingulate Gyrus,
left Thalamus, left Medial Frontal Gyrus, and right cerebellum are displayed in the sagittal view with numbers above each
slice indicating the position of the slice in X coordinates in MNI space.
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Cannabis*Gender Effects. Gender. Female participants showed significant clusters of
increased BOLD response in the bilateral Posterior Cingulate, left Medial Frontal Gyrus, right
Cerebellum, left Superior Occipital Gyrus, the right Cingulate Gyrus, and the left Thalamus
during correct NoGo activation. Cannabis*Gender. There were no significant clusters that
survived correction for the interaction between cannabis use and gender. Covariates. Past year
alcohol use did predict increased BOLD activation within the left Inferior Parietal Lobule.
Happy vs Fearful Go Trials. Follow up whole brain analyses of correct neutral NoGo
and happy Go trials showed significant clusters in the left Anterior Cingulate Cortex, the left
Middle Frontal Gyrus, and the left Parahippocampal Gyrus (see Figure 2). There were no
significant clusters that survived correction in the trial with fearful go stimulus.
Figure 2.
BOLD Responses in Cannabis Users vs Controls in Happy Go Trials

Figure 2. Displays regions of increased significant BOLD responses in cannabis users compared to controls during correct
inhibitions during “neutral” NoGo trials on trials where the Go stimulus was a “happy” face. Increased BOLD response in the
left Frontal Middle Gyrus, left Parahippocampal Gyrus, and the left Cingulate Gyrus are displayed in the sagittal view with
numbers above each slice indicating the position of the slice in X coordinates in MNI space.

Brain-Behavior Relationships
Beta values from regions displaying increased BOLD responses in cannabis users were
not significantly correlated with the Connor CPT, but did show slight positive correlations (see
Table 3) with increased reaction time and increased beta values in the left cingulate gyrus

16

(r(80)=0.10, p=0.37), left superior frontal gyrus (r(80)=0.11, p=0.33), and the left medial frontal
gyrus (r(80)=0.18, p=0.10).
Table 3.
Pearson Correlations of Beta Coefficients of Significant ROI’s
Left Cingulate
Gyrus
Coefficients

Left Superior
Frontal Gyrus
Coefficients

Left
Thalamus
Coefficients

Left Medial
Frontal
Gyrus
Coefficients

Right
Cerebellum
Coefficients

CPT
Average
Hit
Response
Time

Left Cingulate
Gyrus
Coefficients

1

.661**

.639**

.521**

.649**

0.100

Left Superior
Frontal Gyrus
Coefficients

.661**

1

.536**

.412**

.548**

0.109

.639**

.536**

1

.379**

.685**

-0.070

Left Medial
Frontal Gyrus
Coefficients

.521**

.412**

.379**

1

.429**

0.184

Right
Cerebellum
Coefficients

.649**

.548**

.685**

.429**

1

-0.042

CPT Average Hit
Response Time

0.100

0.109

-0.070

0.184

-0.042

1

Left Thalamus
Coefficients

Notes. **. Correlation is significant at the 0.01 level (2-tailed). *. Correlation is significant at the 0.05 level (2-tailed).

Discussion
This study examined BOLD responses between cannabis users and controls during
correct inhibitions of neutral NoGo stimuli. Further, we aimed to determine if gender moderates
the impact of cannabis use on brain activation. The data showed that despite similar behavioral
performance, adolescent and young adult cannabis users demonstrated increased and diffuse
BOLD activation within regions associated with response inhibition even after three weeks of
monitored abstinence. Gender did not moderate these effects.
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Our findings support previous work examining functional and behavioral differences in
response inhibition between cannabis using adolescents and emerging adults and their non-using
counterparts. Cannabis users showed increased BOLD responses within the left superior frontal
gyrus and the left medial gyrus replicating previous findings (Gruber & Yurgelun-Todd, 2005;
Tapert et al., 2007). Similar to past research, cannabis users also demonstrated greater BOLD
activation during response inhibition in the left anterior cingulate cortex (Hester et al., 2009) and
the thalamus (A. M. Smith et al., 2011). Further, as hypothesized, neighboring brain regions
were incorporated showing increased BOLD responses with the significant cluster associated
with the left cingulate cortex being particularly diffuse across the anterior cingulate cortex and
pre-frontal regions of the brain. These findings add to the previous literature which have
produced relatively consistent findings indicating increased BOLD responses in prefrontal
(Behan et al., 2014; Hester et al., 2009; A. M. Smith et al., 2011; Tapert et al., 2007), ACC
(Hester et al., 2009), and thalamus (A. M. Smith et al., 2011) regions. Gruber and colleagues
(2005) did show mixed findings in the directionality of BOLD responses, which may be due to
the use of differing task paradigms (i.e. Stroop versus Go-NoGo). Previous research suggests the
use of the Stroop task may be measuring different mechanisms of inhibition, which differs from
the more “pure” Go-NoGo inhibition task (Garavan et al., 2002; Nigg, 2000). Further, we
previously reported, in an overlapping sample, that the cannabis users had impaired sustained
attention on the CPT-3 task (Wallace et al., 2018) and this increased BOLD response was
positively (although not significantly) correlated with poorer sustained attention. Taken together,
this suggests that the increased BOLD response was not advantageous to the cannabis users.
Other fMRI studies have also reported abnormalities in similar regions, including
increased BOLD responses of the ACC during error monitoring (Hester et al., 2009) and visual
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working memory (Kanayama, Rogowska, Pope, Gruber, & Yurgelun-Todd, 2004) tasks. Altered
activation in prefrontal regions have also been observed during working memory (Alecia D
Schweinsburg et al., 2005) and reward anticipation (Van Hell et al., 2010) tasks, although the
directionality of the BOLD responses (increased vs decreased) remain mixed. Still, these results
support the notion that chronic cannabis use affects brain regions dense in CB1 receptors such as
the ACC (Herkenham et al., 1990). Animal models show that chronic cannabis use leads to a
downregulation of CB1 receptors (González, Cebeira, & Fernández-Ruiz, 2005); therefore,
impacting the natural functioning of the endogenous endocannabinoid system. With this
downregulation in CB1 receptor functioning, differences in BOLD activation (as Tapert et al.
(2007) suggests) may be compensatory in nature and indicating increased need for resources to
perform similar inhibitory response as non-cannabis users in these CB1 rich brain regions. While
these differences in brain functioning may not contribute to observable behavioral differences at
this point of development, continued chronic use could produce downstream behavioral
differences in later years as brain development becomes less plastic. Further exploration into
CB1 receptor functioning and endocannabinoid signaling in the developing human brain may
help elucidate the mechanistic link between chronic cannabis use and long-term neurocognitive
deficits.
This study examined inhibitory control within the context of an affective processing task.
Therefore, in a follow-up analysis, we examined BOLD response to neutral NoGo stimuli during
trials with happy Go stimuli and fearful Go stimuli. To examine the influence of this emotional
environment, we compared BOLD responses during neutral NoGo inhibition within these two
trials in cannabis users compared to controls. During the happy Go block, the areas of activation
were similar to our main findings. However, there were no significant clusters that survived
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corrections in the trials of the fearful Go stimuli. This suggests that the emotional environment
did have an influence on the neuronal response to inhibition in the cannabis users compared to
controls. However, the current power of this study does not support further investigation into the
nature of these supplementary findings. Still, closer examination of how affective states
influence brain responses during response inhibition must be conducted going forward to
determine the true nature of this relationship.
Past findings have wisely pointed out that increased BOLD responses in cannabis users
may be attributed to recent use, in part due to cardiovascular effects of acute cannabis use
(Tapert et al., 2007). However, these increases in blood flow have been shown to vanish by 28
days of last cannabis use (Sneider et al., 2008). Due to the requirement for cannabis users to
remain abstinent for the 21 days leading up to MRI scan, participants last cannabis use on
average occurred 31.08 days prior to scanning. This period of abstinence provides evidence that
these changes in brain functioning are due to chronic cannabis use rather than acute effects.
Indeed, this length of abstinence is linked with resolution of withdrawal symptoms and past work
has shown recovery of cognitive deficits in cannabis users following sustained abstinence
(Hanson et al., 2010; Medina et al., 2007; Schuster et al., 2018). Therefore, this sample of
cannabis users may have demonstrated some recovery of function and findings may not
generalize to more recent users.
We did not find a significant interaction between cannabis use and gender on the effect of
BOLD responses during correct inhibitory responses. It may be that cannabis use does not
disproportionately affect brain functioning or performance between genders in these regions as
previous animal models suggest (Burston et al., 2010; Paola Castelli et al., 2014). Investigations
into gender effects for this cognitive domain remains relatively limited and findings are still
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mixed. While functional studies have not examined gender differences in cannabis users,
structural studies indicate that brain based differences do occur in frontolimbic areas in
adolescent users (Battistella et al., 2014; Gilman et al., 2014; McQueeny et al., 2011; Schacht,
Hutchison, & Filbey, 2012). It is also possible that gender differences exist at earlier adolescent
stages, but gender differences diminish by the early young adult years and the current sample
average age was 20-21. Future studies are needed to examine how cannabis and gender interact
to predict longitudinal neurodevelopment of neuronal areas underlying inhibitory control.
It is also important to note that increased BOLD activity observed in cannabis users may
be premorbid in nature; inherent brain differences in these regions may make individuals more
susceptible to using cannabis in the adolescent and young adult years. Indeed, substance use has
been heavily associated with impaired response inhibition (Ivanov et al., 2008) with substance
users across varying forms of use having been consistently shown to have inhibitory deficits
across a myriad of studies (J. L. Smith et al., 2014). With evidence pointing to deficits in
response suppression in children with high family risk for alcohol use disorder (Nigg et al.,
2006), premorbid deficits of response inhibition may be a potential predictor of future substance
use (Nigg et al., 2006; Squeglia, Jacobus, Nguyen-Louie, & Tapert, 2014). These findings are
further replicated in fMRI studies. Most notably, longitudinal studies examining inhibitory
control have shown that neural activity during inhibition response in adolescents can predict
future substance use (Mahmood et al., 2013; Norman et al., 2011). Prospective, longitudinal
studies are needed to determine whether these observed differences are predictors of cannabis
use onset and increased use and/or direct effects of chronic exposure.
Limitations should be noted. As noted above, the study’s cross-sectional nature prevents
us from determining causality of these increased BOLD responses in cannabis users compared to
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controls. Prospective, longitudinal studies, such as the Adolescent Brain Cognitive Development
(ABCD) Study (Terry L Jernigan, Brown, & Dowling, 2018), will help determine timing and
causality of these findings. Further, the study population was primarily Caucasian, relatively
average to high average education levels, and did not have comorbid medical or physical
disorders. This narrows the generalizability of the study, and more representative samples of the
general population (i.e. the ABCD study) should be utilized to examine these effects in
subgroups.
These findings lend support to the growing literature suggesting that adolescent and
young adult cannabis users demonstrate increased BOLD responses during response inhibition.
These findings suggest that regular cannabis during these neurodevelopmental years may impact
neurodevelopment. Further prospective, longitudinal research is needed to determine causality
and whether sustained abstinence greater than one month is associated with complete recovery
from cannabis effects.
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